Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Marginal Zone Lymphoma – Epidemiology – Epidemiology – Marginal Zone Lymphoma – Mature Markets
Clarivate Epidemiology’s coverage of marginal zone lymphoma (MZL) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States,…
Immune Thrombocytopenic Purpura – Landscape & Forecast – Niche & Rare Disease Landscape & Forecast (US/EU5)
Immune thrombocytopenic purpura (ITP) is an autoimmune disease resulting in a low platelet count. Treatment of ITP involves the use of immunomodulators and corticosteroids as well as multiple…
Non-Hodgkin’s Lymphoma – Unmet Need – Unmet Need – Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Leukemia (US/EU)
Chronic lymphocytic leukemia (CLL) / small lymphocytic lymphoma (SLL) is a type of B-cell non-Hodgkin’s lymphoma and represents the most common form of leukemia in adults. The R/R CLL treatment…
Sickle Cell Disease – Access & Reimbursement – Access & Reimbursement – Sickle Cell Disease (US)
Sickle cell disease (SCD) is a rare genetic blood disorder characterized by polymerization of hemoglobin in red blood cells that distorts them into a sickle shape, leading to various complications…
